Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK

ConditionDry Eye
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorVance Thompson Vision

About this trial

Collecting data using Kera Sol tear usage during the initial two-week post-operative period after Laser-Assisted In Situ Keratomileusis (LASIK) has on the signs and symptoms of surgical temporary ocular discomfort syndrome (STODS)

Eligibility criteria

Qualifiers

Be willing and able to sign the informed consent form (ICF)

Be at least 18 years of age at the screening visit

Be undergoing LASIK treatment in both eyes

Be literate and able to complete questionnaires independently

Disqualifiers

Use of topical prescription dry eye medications such as lifitegrast, cyclosporine, loltilaner, etc.

Have a break in the integrity of the corneal epithelium such as a persistent corneal epithelial defect, or corneal ulcer.

Have presence of corneal pathology that may interfere with LASIK outcomes

Active infectious, ocular or systemic disease

Trial design

Treatments tested in this trial

  • Kera Sol Eye Drops

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

1
Vance Thompson Vision Clinic, Prof. LLC57108, Sioux FallsSouth Dakota, United States

Sponsors and collaborators

Vance Thompson Vision

Lead sponsor